|
X. Wang;F. Markowetz;E. Melo F. De Sousa;J. P. Medema;L. Vermeulen |
Dissecting cancer heterogeneity - An unsupervised classification approach |
|
Int J Biochem Cell Biol |
|
T. Lappalainen;M. Sammeth;M. R. Friedlander;P. A. t Hoen;J. Monlong;M. A. R... |
Transcriptome and genome sequencing uncovers functional variation in humans |
|
Nature |
|
Ong CA, Shapiro J, Nason KS, Davison JM, Liu X, Ross-Innes C, O'Donova... |
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma |
|
J Clin Oncol. |
|
Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kap... |
Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer |
|
Hum Mol Genet. |
|
Griffiths DS, Li J, Dawson MA, Trotter MW, Cheng YH, Smith AM, Mansfield W,... |
LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. |
|
Nat Cell Biol. |
|
Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. |
Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers |
|
Carcinogenesis |
|
Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DWY, Kaper F, Dawson S-J, P... |
Non-invasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA |
|
Science Translational Medicine |
|
Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, Zbinden S, Izzedine H, ... |
Targeted therapies for renal cell carcinoma: review of adverse event manage... |
|
J Natl Cancer Inst. |
|
Pharoah, P. D. P., Tsai, Y. -Y., Ramus, S. J., Phelan, C. M., Goode, E. L.,... |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
|
Nature Genetics |
|
Rodrigues, T. B., Serrao, E. M., Kennedy, B. W. C., Hu, D., Kettunen, M. I.... |
Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C labeled glucose |
|
Nature Med |
